New cream aims to stop vitiligo relapse after repigmentation

NCT ID NCT06446063

Terminated Disease control Sponsor: Pierre Fabre Dermo Cosmetique Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This trial tested a cosmetic cream called RV5098A to see if it could help adults with vitiligo keep their facial pigmentation after successful repigmentation treatment. Vitiligo causes white patches on the skin, and even after treatment, about 40% of people lose color again within a year. The study enrolled 19 participants who applied the cream twice daily to their entire face. However, the trial was terminated early, so we have limited data on whether it works.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: RV5098A (a cosmetic cream)
What this could lead to: If it works, this could help people with vitiligo keep their skin color longer after repigmentation treatment.
What could go wrong: The trial was terminated early with only 19 participants, so results are limited. It is a cosmetic product, not a drug, and may not provide lasting benefit.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for VITILIGO are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Facies vitiligo

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

VITILIGO

Contacts and locations

Locations

COSDERMA

Bordeaux, Gironde, 33000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.